Page 141 - Orange Book Cumulative Supplement 10 October 2012

A - 4
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
BIVALIRUDIN - ANGIOMAX
N020873 001 5196404 Dec 15, 2014 DS DP U-1232
5196404 Dec 15, 2014 DS DP U-1040
5196404*PED Jun 15, 2015
BOCEPREVIR - VICTRELIS
N202258 001 8119602 Mar 17, 2027 U-1233
RE43298 Feb 22, 2022 DS DP U-1128

BORTEZOMIB - VELCADE
N021602 001 NR Jan 23, 2015
BOSUTINIB MONOHYDRATE - BOSULIF
N203341 001 6002008 Mar 27, 2018 DS DP U-1284 NCE Sep 04, 2017
7417148 Jan 23, 2026 U-1283 ODE Sep 04, 2019
7767678 Nov 23, 2026 DS DP
7919625 Dec 11, 2025 DP
RE42376 Sep 24, 2019 DS
BOSUTINIB MONOHYDRATE - BOSULIF
N203341 002 6002008 Mar 27, 2018 DS DP U-1284 NCE Sep 04, 2017
7417148 Jan 23, 2026 U-1283 ODE Sep 04, 2019
7767678 Nov 23, 2026 DS DP
7919625 Dec 11, 2025 DP
RE42376 Sep 24, 2019 DS

BRIMONIDINE TARTRATE; TIMOLOL MALEATE - COMBIGAN
N021398 001 8133890 Apr 19, 2022 U-1235
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT
N021929 001 8143239 Jan 29, 2023 DP U-1073
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT
N021929 002 8143239 Jan 29, 2023 DP U-1073
BUPIVACAINE - EXPAREL
N022496 001 6132766 Nov 16, 2013 DP
8182835 Sep 18, 2018 DP U-1246
BUPIVACAINE - EXPAREL
N022496 002 6132766 Nov 16, 2013 DP
8182835 Sep 18, 2018 DP U-1246

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE
N022410 003 NDF Aug 30, 2013
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE
N022410 004 NDF Aug 30, 2013
CALCIPOTRIENE - SORILUX
N022563 001 8263580 May 26, 2026 DP U-1280 I-657 Sep 27, 2015